No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:

Cost-effectiveness analysis regarding postoperative administration of vitamin-D and calcium after thyroidectomy to prevent hypocalcaemia.

Sanabria Alvaro, Domínguez Luis C, Vega Valentín et al. · Rev Salud Publica (Bogota) · 2011

PMID: 22634947Meta-Analysis

[Tetany as a frequent cause of an emergency consultations--etiology, symptoms and cure].

Gryglas Anna, Dudkowiak Robert, Smigiel Robert · Przegl Lek · 2015

PMID: 26076573Review

Chvostek's sign in paediatric practice.

Hasan Zeeshaan U, Absamara Rania, Ahmed Mas · Curr Pediatr Rev · 2014

PMID: 25088339Review

Calcium and magnesium physiology and nutrition in relation to the prevention of milk fever and tetany (dietary management of macrominerals in preventing disease).

Martín-Tereso Javier, Martens Holger · Vet Clin North Am Food Anim Pract · 2014

PMID: 25245611Review

Myokymia and neuromyotonia in veterinary medicine: a comparison with peripheral nerve hyperexcitability syndrome in humans.

Vanhaesebrouck An E, Bhatti Sofie F M, Franklin Robin J M et al. · Vet J · 2013

PMID: 23583699Review

[Serious adverse effects of blood collection].

Danic B, Lefort C · Transfus Clin Biol · 2010

PMID: 21051270Review

Parathyroid disease.

Wen Hong Yan, Schumacher H Ralph, Zhang Li Yun · Rheum Dis Clin North Am · 2010

PMID: 21092844Review

[Symptoms and management of tetany].

Ito Nobuaki, Fukumoto Seiji · Clin Calcium · 2007

PMID: 17660621Review

Effect of calcium glucoheptonate on proliferation and osteogenesis of osteoblast-like cells in vitro.

Modi Prashant Kumar, Prabhu Ashwini, Bhandary Yashodhar P et al. · PLoS One · 2019

PMID: 31498830OtherFull text (PMC)

Relative bioavailability and pharmacokinetic comparison of calcium glucoheptonate with calcium carbonate.

Wiria Mss, Tran Hung Manh, Nguyen Phuc H B et al. · Pharmacol Res Perspect · 2020

PMID: 32302064TrialFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Calcium gluceptate (substance)
SNOMED CT: 71714008
UMLS CUI: C0108111
RxNorm CUI: 47618
Labeler: AnazaoHealth Corporation

Clinical Data

This intervention maps to 12 entities in the Ltrl knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.